{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-25-000128","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2025-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.006050+00:00","generated_at":"2026-05-17T01:28:47.178062+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cardinal Health Q1 revenue $64B (+22%), non-GAAP EPS $2.55 (+36%); raises FY2026 guidance","bullets":["Revenue $64B (+22% YoY); GAAP diluted EPS $1.88 (+11%); non-GAAP diluted EPS $2.55 (+36%).","Segment profit growth across all five segments; Pharmaceutical & Specialty profit up 26% to $667M.","FY2026 non-GAAP EPS guidance raised to $9.65-$9.85 (from $9.30-$9.50); adjusted free cash flow raised to $3.0-$3.5B.","Acquisition of Solaris Health expected to close early November; initiated $375M accelerated share repurchase in Q1."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-25-000128","json":"https://secwatch.observer/filing/0000721371-25-000128.json","markdown":"https://secwatch.observer/filing/0000721371-25-000128.md","text":"https://secwatch.observer/filing/0000721371-25-000128.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137125000128/0000721371-25-000128-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137125000128/cah-20251030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:28:47.178062+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}